Is Mylan's FDA Warning Letter Worth Worrying About?
August 18, 2015 at 14:33 PM EDT
Mylan NV (NASDAQ: MYL) commented publicly for the first time to a FDA warning letter which it received on August 6, relating to its ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.